{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:27:33Z","timestamp":1792189653931,"version":"4.4.0"},"reference-count":39,"publisher":"Japanese Society of Veterinary Science","issue":"11","funder":[{"name":"Iskara Industry Co., Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1292\/jvms.25-0296","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T22:08:34Z","timestamp":1758146914000},"page":"1238-1248","source":"Crossref","is-referenced-by-count":1,"title":["Potential inhibitory effect of Shigyakusan on gallstone formation in a mice model of cholesterol gallstone Disease"],"prefix":"10.1292","volume":"87","author":[{"given":"Go","family":"UTSUNOMIYA","sequence":"first","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"SHINOHARA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"},{"name":"Pet Health &amp; Food Division, Iskara Industry Co., Ltd., Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"KURIHARA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"LIU","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"ISHIHARA","sequence":"additional","affiliation":[{"name":"CAPITAL, Kanagawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minami","family":"KOBAYASHI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"ELBADAWY","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"},{"name":"Department of Pharmacology, Faculty of Veterinary Medicine, Benha University, Elqaliobiya, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"ABUGOMAA","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"},{"name":"Faculty of Veterinary Medicine, Mansoura University, Dakahliya, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"USUI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"SASAKI","sequence":"additional","affiliation":[{"name":"Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"122","reference":[{"key":"1","unstructured":"1. Aihara N, Tazuma S, Ohya T, Hatsushika S, Yamashita Y, Horikawa K, Ochi H, Teramen K, Hirano T, Miura H, Sasaki M, Kajiyama G.  1994. Inhibitory effects of Dai-saiko-to (TJ-8) on the cholesterol gallstone formation in hamsters. <i>Tando<\/i> 8: 9\u201313."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Akiyoshi T, Uchida K, Takase H, Nomura Y, Takeuchi N.  1986. Cholesterol gallstones in alloxan-diabetic mice. <i>J Lipid Res<\/i> 27: 915\u2013924.","DOI":"10.1016\/S0022-2275(20)38774-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, Hobbs HH.  2000. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. <i>Science<\/i> 290: 1771\u20131775.","DOI":"10.1126\/science.290.5497.1771"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Boyer JL.  2013. Bile formation and secretion. <i>Compr Physiol<\/i> 3: 1035\u20131078.","DOI":"10.1002\/j.2040-4603.2013.tb00519.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chang HJ, Suh JI, Kwon SY.  1999. Gallstone formation and gallbladder mucosal changes in mice fed a lithogenic diet. <i>J Korean Med Sci<\/i> 14: 286\u2013292.","DOI":"10.3346\/jkms.1999.14.3.286"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen Q, Zhang Y, Li S, Chen S, Lin X, Li C, Asakawa T.  2019. Mechanisms underlying the prevention and treatment of cholelithiasis using traditional Chinese medicine. <i>Evid Based Complement Alternat Med<\/i> 2019: 2536452.","DOI":"10.1155\/2019\/2536452"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Clarke SF, Murphy EF, O\u2019Sullivan O, Lucey AJ, Humphreys M, Hogan A, Hayes P, O\u2019Reilly M, Jeffery IB, Wood-Martin R, Kerins DM, Quigley E, Ross RP, O\u2019Toole PW, Molloy MG, Falvey E, Shanahan F, Cotter PD.  2014. Exercise and associated dietary extremes impact on gut microbial diversity. <i>Gut<\/i> 63: 1913\u20131920.","DOI":"10.1136\/gutjnl-2013-306541"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Di Ciaula A, Wang DQ, Portincasa P.  2018. An update on the pathogenesis of cholesterol gallstone disease. <i>Curr Opin Gastroenterol<\/i> 34: 71\u201380.","DOI":"10.1097\/MOG.0000000000000423"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Duan Y, Gong K, Xu S, Zhang F, Meng X, Han J.  2022. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. <i>Signal Transduct Target Ther<\/i> 7: 265.","DOI":"10.1038\/s41392-022-01125-5"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fujita N, Yasuda I, Endo I, Isayama H, Iwashita T, Ueki T, Uemura K, Umezawa A, Katanuma A, Katayose Y, Suzuki Y, Shoda J, Tsuyuguchi T, Wakai T, Inui K, Unno M, Takeyama Y, Itoi T, Koike K, Mochida S.  2023. Evidence-based clinical practice guidelines for cholelithiasis 2021. <i>J Gastroenterol<\/i> 58: 801\u2013833.","DOI":"10.1007\/s00535-023-02014-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Gao Q, Bi P, Mi Q, Guan Y, Jiang J, Li X, Yang B.  2023. Effect of nicotine on cholesterol gallstone formation in C57BL\/6J mice fed on a lithogenic diet. <i>Exp Ther Med<\/i> 25: 84.","DOI":"10.3892\/etm.2023.11783"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Honda K, Saneyasu T, Hasegawa S, Tominaga Y, Yokota S, Kamisoyama H.  2013. Effect of licorice flavonoid oil on cholesterol metabolism in high fat diet rats. <i>Biosci Biotechnol Biochem<\/i> 77: 1326\u20131328.","DOI":"10.1271\/bbb.130104"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Jaunoo SS, Mohandas S, Almond LM.  2010. Postcholecystectomy syndrome (PCS). <i>Int J Surg<\/i> 8: 15\u201317.","DOI":"10.1016\/j.ijsu.2009.10.008"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jiang ZY, Parini P, Eggertsen G, Davis MA, Hu H, Suo GJ, Zhang SD, Rudel LL, Han TQ, Einarsson C.  2008. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. <i>J Lipid Res<\/i> 49: 464\u2013472.","DOI":"10.1194\/jlr.M700295-JLR200"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Khalil M, Gena P, Di Ciaula A, Portincasa P, Calamita G.  2024. Aquaporins in biliary function: pathophysiological implications and therapeutic targeting. <i>Int J Mol Sci<\/i> 25: 25.","DOI":"10.3390\/ijms252212133"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Krawczyk M, L\u00fctjohann D, Schirin-Sokhan R, Villarroel L, Nervi F, Pimentel F, Lammert F, Miquel JF.  2012. Phytosterol and cholesterol precursor levels indicate increased cholesterol excretion and biosynthesis in gallstone disease. <i>Hepatology<\/i> 55: 1507\u20131517.","DOI":"10.1002\/hep.25563"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lammert F, Gurusamy K, Ko CW, Miquel JF, M\u00e9ndez-S\u00e1nchez N, Portincasa P, van Erpecum KJ, van Laarhoven CJ, Wang DQ.  2016. Gallstones. <i>Nat Rev Dis Primers<\/i> 2: 16024.","DOI":"10.1038\/nrdp.2016.24"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lammert F, Wang DQ, Hillebrandt S, Geier A, Fickert P, Trauner M, Matern S, Paigen B, Carey MC.  2004. Spontaneous cholecysto- and hepatolithiasis in Mdr2-\/- mice: a model for low phospholipid-associated cholelithiasis. <i>Hepatology<\/i> 39: 117\u2013128.","DOI":"10.1002\/hep.20022"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liu M, Liu C, Chen H, Huang X, Zeng X, Zhou J, Mi S.  2017. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL\/6 mouse model. <i>Eur J Pharmacol<\/i> 815: 1\u20139.","DOI":"10.1016\/j.ejphar.2017.10.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Moscati RM.  1996. Cholelithiasis, cholecystitis, and pancreatitis. <i>Emerg Med Clin North Am<\/i> 14: 719\u2013737.","DOI":"10.1016\/S0733-8627(05)70276-5"},{"key":"21","unstructured":"21. Noriaki O, Kazuki N, Teruyoshi Y.  2000. The verification of regulatory effects of Kampo formulations on body fluid using model mice. <i>Wakanyaku<\/i> 17: 131\u2013136."},{"key":"22","unstructured":"22. Ohta Y.  1997. Preventive effect of Saiko-keishi-to and Shigyaku-san extracts on the progression of hepatobilirary injury induced by \u03b1-naphthylisothiocyanate. <i>J. Trad. Med<\/i> 14: 143\u2013148."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Oude Elferink RP, Beuers U.  2011. Targeting the ABCB4 gene to control cholesterol homeostasis. <i>Expert Opin Ther Targets<\/i> 15: 1173\u20131182.","DOI":"10.1517\/14728222.2011.607163"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Park Y, Kim D, Lee JS, Kim YN, Jeong YK, Lee KG, Choi D.  2017. Association between diet and gallstones of cholesterol and pigment among patients with cholecystectomy: a case-control study in Korea. <i>J Health Popul Nutr<\/i> 36: 39.","DOI":"10.1186\/s41043-017-0116-y"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Patel SB, Graf GA, Temel RE.  2018. ABCG5 and ABCG8: more than a defense against xenosterols. <i>J Lipid Res<\/i> 59: 1103\u20131113.","DOI":"10.1194\/jlr.R084244"},{"key":"26","unstructured":"26. Portincasa P, van de Meeberg P, van Erpecum KJ, Palasciano G, VanBerge-Henegouwen GP.  1997. An update on the pathogenesis and treatment of cholesterol gallstones. <i>Scand J Gastroenterol Suppl<\/i> 223: 60\u201369."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Qiao T, Ma RH, Luo XB, Yang LQ, Luo ZL, Zheng PM.  2013. The systematic classification of gallbladder stones. <i>PLoS One<\/i> 8: e74887.","DOI":"10.1371\/journal.pone.0074887"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Reshetnyak VI.  2012. Concept of the pathogenesis and treatment of cholelithiasis. <i>World J Hepatol<\/i> 4: 18\u201334.","DOI":"10.4254\/wjh.v4.i2.18"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Shen W, Shao W, Wang Q, Wang B, Zhao G, Gu A, Jiang Z, Hu H.  2023. Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice. <i>J Biomed Sci<\/i> 30: 44.","DOI":"10.1186\/s12929-023-00933-3"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sun H, Warren J, Yip J, Ji Y, Hao S, Han W, Ding Y.  2022. Factors influencing gallstone formation: a review of the literature. <i>Biomolecules<\/i> 12: 550.","DOI":"10.3390\/biom12040550"},{"key":"31","unstructured":"31. Tsunoda K, Shirai Y, Hatakeyama K.  2004. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. <i>Hepatogastroenterology<\/i> 51: 1271\u20131274."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. van Erpecum KJ, Wang DQ, Moschetta A, Ferri D, Svelto M, Portincasa P, Hendrickx JJ, Schipper M, Calamita G.  2006. Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. <i>J Lipid Res<\/i> 47: 32\u201341.","DOI":"10.1194\/jlr.M500180-JLR200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang TY, Portincasa P, Liu M, Tso P, Wang DQ.  2018. Mouse models of gallstone disease. <i>Curr Opin Gastroenterol<\/i> 34: 59\u201370.","DOI":"10.1097\/MOG.0000000000000417"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Xu GQ, Xu CF, Chen HT, Liu S, Teng XD, Xu GY, Yu CH.  2014. Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in mice. <i>World J Gastroenterol<\/i> 20: 9513\u20139518.","DOI":"10.3748\/wjg.v20.i28.9513"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Yoshioka H, Fukaya S, Onosaka S, Nonogaki T, Nagatsu A.  2016. Kampo formula \u201cHochu-ekki-to\u201d suppressed carbon tetrachloride-induced hepatotoxicity in mice. <i>Environ Health Prev Med<\/i> 21: 579\u2013584.","DOI":"10.1007\/s12199-016-0571-x"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Yousef AA, Zedan AM, Zayed ME, Elmoghazy MA.  2020. Incidence and aetiology of gallstones formation after laparoscopic sleeve gastrectomy (retrospective study). <i>Benha Journal of Applied Sciences<\/i> 5: 313\u2013318.","DOI":"10.21608\/bjas.2020.136690"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Zhang Z, Du Z, Liu Q, Wu T, Tang Q, Zhang J, Huang C, Huang Y, Li R, Li Y, Zhao Y, Zhang G, Zhou J, Huang H, Fang Z, He J.  2021. Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity. <i>Metabolism<\/i> 118: 154728.","DOI":"10.1016\/j.metabol.2021.154728"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Zhou Q, Hu H, Zhao G, Liu P, Wang Y, Zhang H.  2021. Effect and related mechanism of Yinchenhao decoction on mice with lithogenic diet-induced cholelithiasis. <i>Exp Ther Med<\/i> 21: 316.","DOI":"10.3892\/etm.2021.9747"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Zhu F, Li YM, Feng TT, Wu Y, Zhang HX, Jin GY, Liu JP.  2019. Freeze-dried Si-Ni-San powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease. <i>World J Gastroenterol<\/i> 25: 3056\u20133068.","DOI":"10.3748\/wjg.v25.i24.3056"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/11\/87_25-0296\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:16:59Z","timestamp":1761970619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jvms\/87\/11\/87_25-0296\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.25-0296","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"25-0296"}}